1. Home
  2. IPHA vs ESP Comparison

IPHA vs ESP Comparison

Compare IPHA & ESP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Innate Pharma S.A. ADS

IPHA

Innate Pharma S.A. ADS

HOLD

Current Price

$1.75

Market Cap

189.5M

Sector

Health Care

ML Signal

HOLD

Logo Espey Mfg. & Electronics Corp.

ESP

Espey Mfg. & Electronics Corp.

HOLD

Current Price

$61.75

Market Cap

165.6M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
IPHA
ESP
Founded
1999
1928
Country
France
United States
Employees
163
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
189.5M
165.6M
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
IPHA
ESP
Price
$1.75
$61.75
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
1
Target Price
$5.75
$64.00
AVG Volume (30 Days)
16.4K
17.5K
Earning Date
03-26-2026
05-13-2026
Dividend Yield
N/A
1.50%
EPS Growth
N/A
N/A
EPS
N/A
2.74
Revenue
N/A
$43,950,872.00
Revenue This Year
$180.36
$10.30
Revenue Next Year
N/A
$10.00
P/E Ratio
N/A
$22.25
Revenue Growth
N/A
N/A
52 Week Low
$1.18
$36.00
52 Week High
$2.63
$74.77

Technical Indicators

Market Signals
Indicator
IPHA
ESP
Relative Strength Index (RSI) 53.70 52.79
Support Level $1.73 $53.68
Resistance Level $1.90 $61.58
Average True Range (ATR) 0.07 2.36
MACD -0.01 0.68
Stochastic Oscillator 55.59 83.27

Price Performance

Historical Comparison
IPHA
ESP

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. The company's approach includes therapeutic modalities such as monoclonal antibodies, multispecific NK cell engagers through its ANKET platform, and antibody-drug conjugates (ADC). Its portfolio includes lacutamab, which is being studied for cutaneous T-cell lymphomas and peripheral T-cell lymphomas, and monalizumab, which is being developed in collaboration with AstraZeneca for non-small cell lung cancer. The company's revenue mainly consists of revenues from collaboration and licensing agreements and government financing for research expenditure in the form of research tax credits, as well as other grants.

About ESP Espey Mfg. & Electronics Corp.

Espey Manufacturing & Electronics Corp is a power electronics design and OEM manufacturing company delivering products for military and severe environment applications. Its products include power supplies, power converters, filters, power transformers, magnetic components, power distribution equipment, UPS systems, and antennas. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power. Espey services include design and development to specification, build to specifications provided by the customer, build to print, design services, design studies, environmental testing services, metal fabrication, painting services, and development of automatic testing equipment.

Share on Social Networks: